{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:08:16Z","timestamp":1790665696294,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bbmt.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T05:09:06Z","timestamp":1529039346000},"page":"2133-2138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3100-1298","authenticated-orcid":false,"given":"Santosha","family":"Vardhana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Hamlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Zelenetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Matasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig H.","family":"Moskowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbmt.2018.06.009_bib0001","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/1097-0142(19821201)50:11<2486::AID-CNCR2820501138>3.0.CO;2-G","article-title":"Primary non-Hodgkin's lymphoma of the mediastinum","volume":"50","author":"Levitt","year":"1982","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bbmt.2018.06.009_bib0002","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9343(80)90294-6","article-title":"Primary mediastinal lymphoma in adults","volume":"68","author":"Lichtenstein","year":"1980","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.bbmt.2018.06.009_bib0003","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2018.06.009_bib0004","series-title":"Pathology and genetics of tumors of hematopoietic amd lymphoid tissues","author":"Jaffe","year":"2001"},{"issue":"3","key":"10.1016\/j.bbmt.2018.06.009_bib0005","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1200\/JCO.1999.17.3.784","article-title":"Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group","volume":"17","author":"Abou-Elella","year":"1999","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"10.1016\/j.bbmt.2018.06.009_bib0006","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2141.2005.05661.x","article-title":"Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999","volume":"130","author":"Hamlin","year":"2005","journal-title":"British journal of haematology"},{"issue":"7","key":"10.1016\/j.bbmt.2018.06.009_bib0007","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1200\/JCO.1993.11.7.1336","article-title":"Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients","volume":"11","author":"Kirn","year":"1993","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"6769","key":"10.1016\/j.bbmt.2018.06.009_bib0008","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbmt.2018.06.009_bib0009","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/10428190802108870","article-title":"Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma","volume":"49","author":"Kuruvilla","year":"2008","journal-title":"Leukemia & lymphoma"},{"issue":"1","key":"10.1016\/j.bbmt.2018.06.009_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.1998.16.1.63","article-title":"High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome","volume":"16","author":"Popat","year":"1998","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.bbmt.2018.06.009_bib0011","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood.V91.2.717","article-title":"Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation","volume":"91","author":"Sehn","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bbmt.2018.06.009_bib0012","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\"Groupe d'Etude des Lymphomes de l'Adulte\") study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"American Journal of Surgical Pathology"},{"issue":"10","key":"10.1016\/j.bbmt.2018.06.009_bib0013","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2003-11-3911","article-title":"Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma","volume":"103","author":"Kewalramani","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bbmt.2018.06.009_bib0014","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1200\/JCO.1999.17.12.3776","article-title":"Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma","volume":"17","author":"Moskowitz","year":"1999","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bbmt.2018.06.009_bib0015","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"10.1016\/j.bbmt.2018.06.009_bib0016","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.bbmt.2018.06.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables","volume":"34","author":"Cox","year":"1972","journal-title":"Journal of the Royal Statistical Society Series B-Statistical Methodology"},{"issue":"4","key":"10.1016\/j.bbmt.2018.06.009_bib0018","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbmt.2006.12.452","article-title":"The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission","volume":"13","author":"Lerner","year":"2007","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"issue":"3","key":"10.1016\/j.bbmt.2018.06.009_bib0019","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/10428194.2015.1067700","article-title":"A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy","volume":"57","author":"Binkley","year":"2016","journal-title":"Leukemia & lymphoma"},{"issue":"17","key":"10.1016\/j.bbmt.2018.06.009_bib0020","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1200\/JCO.2013.51.7524","article-title":"[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study","volume":"32","author":"Martelli","year":"2014","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"10.1016\/j.bbmt.2018.06.009_bib0021","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/annonc\/mdq418","article-title":"Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study","volume":"22","author":"Rieger","year":"2011","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"3","key":"10.1016\/j.bbmt.2018.06.009_bib0022","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/10428194.2013.810738","article-title":"Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease","volume":"55","author":"Soumerai","year":"2014","journal-title":"Leukemia & lymphoma"},{"issue":"15","key":"10.1016\/j.bbmt.2018.06.009_bib0023","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"The New England journal of medicine"},{"issue":"21","key":"10.1016\/j.bbmt.2018.06.009_bib0024","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/blood.V116.21.420.420","article-title":"Sequential Dose-Dense RCHOP Followed by ICE Consolidation (MSKCC protocol 01-142) without Radiotherapy for Patients with Primary Mediastinal Large B Cell Lymphoma","volume":"116","author":"Moskowitz","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bbmt.2018.06.009_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hon.858","article-title":"Primary mediastinal large cell lymphoma (PMBL): frontline treatment with autologous stem cell transplantation (ASCT). The GEL-TAMO experience","volume":"26","author":"Rodriguez","year":"2008","journal-title":"Hematological oncology"},{"key":"10.1016\/j.bbmt.2018.06.009_bib0026","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1038\/bcj.2015.101","article-title":"High-dose chemotherapy followed by autologous stem cell transplantation for relapsed\/refractory primary mediastinal large B-cell lymphoma","volume":"5","author":"Aoki","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.bbmt.2018.06.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-017-0063-7","article-title":"Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation","author":"Avivi","year":"2018","journal-title":"Bone marrow transplantation"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118303215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118303215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:04:01Z","timestamp":1761059041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118303215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1083879118303215"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.06.009","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}